MB:MILMediobanca - Banca di Credito Finanziario S.p.A. Analysis
Data as of 2026-07-20 - not real-time
Latest Price
Risk Level: Medium
Executive Summary
Mediobanca is trading at €27.06, comfortably above its 20‑day (€26.60), 50‑day (€24.32) and 200‑day (€19.20) simple moving averages, signalling a sustained bullish bias. The RSI sits at 64.9, indicating momentum is strong but not yet overbought, while the MACD histogram has turned negative and the line sits below the signal, hinting at a short‑term bearish pressure near the resistance zone of €27.81. Volatility remains elevated at roughly 30% over the past 30 days, yet the stock’s beta of 0.45 suggests it is less sensitive to broader market swings, offering a defensive edge in a volatile environment. On the valuation side, the forward PE of 15.0 is modestly below the current PE of 18.4, and the dividend yield of 4.67% with a 78% payout ratio provides an attractive income component, though growth is muted with revenue expanding only 0.5% year‑over‑year. Compared with the industry average PE of 17.7, the stock appears fairly priced, while analyst consensus (median target €27.15) aligns closely with the current level, implying limited upside but solid downside protection at the identified support of €25.65. The combination of a strong dividend, low beta, and price stability above key moving averages supports a value‑oriented, income‑focused investment thesis.
Market Outlook
Short Term
< 1 yearKey Factors
- Price near resistance at €27.81
- Bearish MACD crossover
- Elevated RSI approaching overbought levels
Medium Term
1–3 yearsKey Factors
- Price above all major SMAs indicating trend strength
- Attractive dividend yield of 4.67% with sustainable payout
- Fair valuation relative to peers and analyst median target
Long Term
> 3 yearsKey Factors
- Low beta (0.45) providing defensive characteristics
- Consistent income generation through dividends
- Value orientation with modest growth and solid balance‑sheet liquidity
Key Metrics & Analysis
Financial Health
Technical Analysis
Valuation
Risk Assessment
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.